Organic & Biomolecular Chemistry
Communication
for the discovery that CDH produces highly enantioenriched 13C NMR kinetic studies with in situ production of 13C-labeled
acetoin from pyruvate as the sole substrate, because it is incap- α-KG
able of producing acetolactate.
MenD (500 μg mL−1), L-GluDH (4 U mL−1), NADH oxidase (25
U mL−1), L-[1,2-13C]glutamic acid (30 mM), NAD+ (5 mM) and
DTT (5 mM) were incubated with 13C-labeled pyruvate (30 mM)
Experimental
General procedures
in the reaction buffer (750 μL) at 30 °C directly in an NMR
tube. The reactions were followed by in situ NMR experiments.
Nuclear magnetic resonance (NMR) spectra were recorded on a
Deuterium labeling experiments
DRX 400 (Bruker) operating at 400 and 100 MHz for 1H and 13
C
The general procedure for formation of 1 or 2 was followed.
Formation of 1 and 2 was confirmed by NMR and the reaction
mixtures were then lyophilized. The solid residues were dis-
solved in D2O (1.5 mL) and were incubated for a further
48 hours.
For 1: δD (CH3OH) 2.8 (br s); δC (CD3OD) 20.0 (CH3), 32.6
(CH2), 35.5 (br, CH2), 74.2 (CH), 181.2 (COOH), 216.1 (br,
CvO).
acquisitions, respectively. Coupling constants (J) are reported
in Hertz (Hz). Circular dichroism (CD) was measured using a
spectral polarimeter J-810 (Jasco International). High-perform-
ance liquid chromatography (HPLC-DAD) was performed on
an HP 1100 chromatography system (Agilent). HPLC-DAD with
MS/MS (LC-MS) was performed using API2000 with a Turbo-
lonSprayTM source, EI, MRM scan (Applied Biosystems). LC on a
chiral phase was performed on an Astec Chirobiotic T 5 μm
column, at 5 °C, eluted at 0.3 mL min−1 with methanol, 0.1%
acetic acid and 0.4% triethylamine. GC on a chiral phase was
performed on GC-2010 (FID) at 70 °C equipped with the injec-
tor AOC-20 (Shimadzu) using a Macherey-Nagel, FS-Lipodex D
column (50.0 m × 0.25 mm).
13C NMR studies of YerE-catalyzed carboligation of pyruvate
and 2-oxobutyrate
YerE (1 mg mL−1) and 2-oxobutyrate (50 mM) were incubated
with [1,2-13C] or [2-13C]pyruvate (50 mM) in the reaction buffer
(750 μL) at 25 °C directly in an NMR tube. 13C NMR spectra
were recorded with a time delay between spectra of 30 min.
Other general procedures are given in the ESI.†
General procedure for formation of 1 or 2
MenD or SucA (500 μg mL−1) and α-KG (30 mM) was incubated
with pyruvate or acetaldehyde (30 mM) in a reaction buffer
(1.5 mL; 50 mM phosphate, 2 mM MgCl2, 0.1 mM ThDP, 10%
(v/v) D2O, pH = 8) at 30 °C and 300 rpm using a thermomixer
(Eppendorf). After 48 h, the sample was used for NMR without
any further purification.
SucA-catalyzed acetoin formation
SucA (700 μg mL−1) and pyruvate or acetaldehyde (50 mM)
were incubated in the reaction buffer (1.5 mL) at 30 °C and
300 rpm using a thermomixer (Eppendorf). After 48 h, the
sample was used for NMR and GC measurements without any
further purification. Chiral GC: tR(R) = 17.6 min, tR(S) =
13.2 min.
For in situ 13C NMR experiments, 15 mM of each substrate
was incubated in 750 μL of the reaction buffer directly in an
NMR tube under the same conditions as above. For selected
kinetic experiments, the time delay between spectra was
60 min.
CDH-catalyzed acetoin formation
CDH (1 mg mL−1) and pyruvate (25 mM) were incubated in the
reaction buffer (1.5 mL; 50 mM MES, 3 mM MgSO4, 0.5 mM
ThDP, 10% (v/v) D2O, pH = 6.5) at 30 °C and 300 rpm using a
thermomixer (Eppendorf). After 24 and 48 h, the sample was
used for GC measurements without any further purification.
For in situ 13C-NMR, [1,2-13C2]pyruvate (25 mM) was incu-
bated in the reaction buffer (750 μL) directly in an NMR tube
under the same conditions as above. The time delay between
spectra was 30 min.
For in situ CD experiments,9 15 mM of each substrate was
incubated in the reaction buffer in a 0.1 cm path length cell at
30 °C. The spectra were first recorded with the buffer to make
sure that there is no background signal. The reactions were
initiated by addition of the enzyme and the spectra were
recorded in the range of 240–350 nm. The time delay between
spectra was 60 min.
5-Hydroxy-4-oxohexanoic acid 1, δH (D2O) 1.26 (3 H, d,
J 7.1), 2.27–2.32 (2 H, m), 2.65–2.70 (2 H, m) and 4.32 (1 H, q,
J 7.1); δC (D2O) 18.4 (CH3), 30.8 (CH2), 34.1 (CH2), 72.8 (CH),
181.3 (COOH) and 215.8 (CvO); Chiral LC-MS: tR(R) = 6.8 min,
tR(S) = 6.2 min; MS/MS: 145 (parent ion, M − H+), 127, 101,
and 83 (fragment ions).
Acknowledgements
This paper is dedicated to Prof. Dr Maria-Regina Kula on the
4-Hydroxy-5-oxohexanoic acid 2, δH (D2O) 1.67–1.76 (2 H, occasion of her 75th birthday. We are grateful to F. Bonina and
m), 1.96–2.05 (2 H, m), 2.14 (3 H, s), 4.22 (1 H, dd, J 8.3, 3.9); S. Waltzer for technical assistance. Carsten Lanzerath is
δC (D2O) 25.3 (CH3), 28.9 (CH2), 29.0 (CH2), 76.4 (CH), 182.0 acknowledged for his kind assistance in providing L-GluDH
(COOH), 214.8 (CvO); Chiral LC-MS: tR(R) = 16.2 min, tR(S) = and NADH-oxidase enzymes. We thank the DFG (FOR 1296)
17.3 min; MS/MS: 145 (parent ion, M − H+), 127, 101, and 83 and the DBU (ChemBioTech: AZ13234-32) for financial
(fragment ions).
support.
This journal is © The Royal Society of Chemistry 2013
Org. Biomol. Chem., 2013, 11, 252–256 | 255